Your browser doesn't support javascript.
loading
Zoledronate in combination with chemotherapy and surgery to treat osteosarcoma (OS2006): a randomised, multicentre, open-label, phase 3 trial.
Piperno-Neumann, Sophie; Le Deley, Marie-Cécile; Rédini, Françoise; Pacquement, Hélène; Marec-Bérard, Perrine; Petit, Philippe; Brisse, Hervé; Lervat, Cyril; Gentet, Jean-Claude; Entz-Werlé, Natacha; Italiano, Antoine; Corradini, Nadège; Bompas, Emmanuelle; Penel, Nicolas; Tabone, Marie-Dominique; Gomez-Brouchet, Anne; Guinebretière, Jean-Marc; Mascard, Eric; Gouin, François; Chevance, Aurélie; Bonnet, Naïma; Blay, Jean-Yves; Brugières, Laurence.
Afiliação
  • Piperno-Neumann S; Medical Oncology Department, Institut Curie, Paris, France. Electronic address: sophie.piperno-neumann@curie.fr.
  • Le Deley MC; Paris-Saclay University, Paris-Sud University, CESP, INSERM, Villejuif, France; Biostatistics Unit, Gustave Roussy, Villejuif, France.
  • Rédini F; UMR 957, INSERM, Université de Nantes, France.
  • Pacquement H; Pediatric Oncology Department, Institut Curie, Paris, France.
  • Marec-Bérard P; Pediatric Oncology Department, Centre Léon Bérard, Lyon, France.
  • Petit P; Department of Radiology, CHU La Timone, Marseille, France.
  • Brisse H; Department of Radiology, Institut Curie, Paris, France.
  • Lervat C; Pediatric Oncology Department, Centre Oscar Lambret, Lille, France.
  • Gentet JC; Pediatric Oncology Department, CHU La Timone, Marseille, France.
  • Entz-Werlé N; Pediatric Oncology Department, CHU Hautepierre, Strasbourg, France.
  • Italiano A; Medical Oncology Department, Institut Bergonié, Bordeaux, France.
  • Corradini N; Pediatric Oncology Department, Hôpital Mère-enfant, Nantes, France.
  • Bompas E; Medical Oncology Department, Institut de Cancérologie de l'Ouest, Saint Herblain, France.
  • Penel N; Medical Oncology Department, Centre Oscar Lambret, Lille, France.
  • Tabone MD; Pediatric Oncology Department, Hôpital Trousseau, Paris, France.
  • Gomez-Brouchet A; Pathology Department, CHU Toulouse, France.
  • Guinebretière JM; Pathology Department, Institut Curie, Saint-Cloud, France.
  • Mascard E; Pediatric Orthopedic Surgery Department, Hôpital Necker Enfants Malades, Paris, France.
  • Gouin F; CHU Hôtel-Dieu, and INSERM UI957, Nantes, France.
  • Chevance A; Biostatistics Unit, Gustave Roussy, Villejuif, France.
  • Bonnet N; Unicancer, Paris, France.
  • Blay JY; Medical Oncology Department Centre Léon Bérard, and Claude Bernard University, Lyon, France.
  • Brugières L; Department of Children and Adolescents Oncology, Gustave Roussy, Villejuif, France.
Lancet Oncol ; 17(8): 1070-1080, 2016 Aug.
Article em En | MEDLINE | ID: mdl-27324280

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ósseas / Protocolos de Quimioterapia Combinada Antineoplásica / Osteossarcoma Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ósseas / Protocolos de Quimioterapia Combinada Antineoplásica / Osteossarcoma Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article